Monitoring respiratory complications during gastroscopy procedures
The Effects of Ketamine and Propofol and Remifentanil and Propofol Combinations on Integrated Pulmonary Index During Sedation in Gastroscopy
This study is testing if a new monitoring tool can help keep track of breathing problems in adults having a gastroscopy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Gaziosmanpasa Research and Education Hospital Government |
| Locations | 1 site (Istanbul, Gaziosmanpaşa) |
| Trial ID | NCT05829486 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of the Integrated Pulmonary Index (IPI) in monitoring respiratory complications in patients undergoing gastroscopy. The IPI combines measurements of oxygen saturation, end-tidal carbon dioxide concentration, respiratory rate, and heart rate into a single numerical value to assess respiratory status. Patients will be continuously monitored during sedation to identify any potential respiratory issues that may arise. The study will include patients classified as ASA 1-3 risk scores who are over 18 years old and scheduled for endoscopic procedures.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old with ASA 1-3 risk scores who are scheduled for gastroscopy.
Not a fit: Patients requiring mechanical ventilator support or those needing emergency endoscopic interventions will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the safety of sedation practices in endoscopic procedures by improving the monitoring of respiratory complications.
How similar studies have performed: While the use of IPI in monitoring has shown promise, this specific application in gastroscopy is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ASA 1-2-3 risk scored patients, * patients over the age of 18 who will undergo endoscopic intervention Exclusion Criteria: * Patients who need mechanical ventilator support, * patients who need emergency endoscopic intervention, * patients with a history of substance abuse, * patients with a history of allergy to the drugs to be used, * pregnant women will be excluded from the study.
Where this trial is running
Istanbul, Gaziosmanpaşa
- Gaziosmanpaşa TREH — Istanbul, Gaziosmanpaşa, Turkey (Recruiting)
Study contacts
- Principal investigator: zuhal çavuş, MD — gaziosmanpasa TREH
- Study coordinator: sibel bektas, MD
- Email: sibel-bektas@yahoo.com
- Phone: 02129453030
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.